D. E. Shaw & Co., Inc. Instil Bio, Inc. Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.37 $369,024 - $584,883	-79,360 Reduced 31.06%	176,155 $853,000
Q2 2022 Aug 15, 2022	BUY	$4.21 - $11.15 $934,948 - $2.48 Million	222,078 Added 664.17%	255,515 $1.18 Million
Q1 2022 May 16, 2022	BUY	$8.48 - $18.1 $193,462 - $412,933	22,814 Added 214.76%	33,437 $359,000
Q4 2021 Feb 14, 2022	BUY	$15.37 - $22.5 $163,275 - $239,017	10,623 New	10,623 $182,000
Q3 2021 Nov 15, 2021	SELL	$15.05 - $23.28 $638,977 - $988,398	-42,457 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$15.31 - $24.63 $650,016 - $1.05 Million	42,457 New	42,457 $820,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $3.23B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.